Scandinavian ChemoTech AB (publ) signed an extension of the existing credit lines amounting to SEK 6 Million, which provides the company with SEK 2 Million in unused funds in addition to the existing liquidity of SEK 4 Million and excluding the last months orders of SEK 1.7 Million. After comparing terms given from several debt finance options, the company has taken these loans to the best market terms available, with an interest rate of 4.5% per quarter and a setup fee of 5%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.24 SEK | -1.32% | 0.00% | -17.04% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.04% | 3.66M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- CMOTEC B Stock
- News Scandinavian ChemoTech AB
- Scandinavian ChemoTech AB Renews Existing Loans from External Lenders, Larger Shareholders and Members of the Board and CEO